Incidence, outcomes, and predictors of new heart failure in syrian conflict-affected population following hospitalization for atrial fibrillation: A retrospective cohort study.

Syria atrial fibrillation conflict heart failure mortality readmission

Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
10 Sep 2024
Historique:
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: aheadofprint

Résumé

Atrial fibrillation (AF) is the most common arrhythmia worldwide. Data regarding readmission for new congestive heart failure (CHF) following index admission for AF in the developing world are poorly described. The study aimed to assess the rate, predictors, and outcomes of 120-day CHF readmission after index admission for AF in Syria. This retrospective cohort study collected all adult patients without known CHF who had an index admission with AF to Latakia's tertiary center between June 2021-December 2023. Data were taken from patients' medical notes. The primary outcome included readmission with incident CHF within 120 of index discharge, and secondary outcomes included predictors and outcomes of these CHF readmissions. A total of 660 patients were included in the final analysis, of which 69 (11.7%) were readmitted with new CHF within 120 days of index discharge. Readmitted patients had higher median age (58 vs 70 years, Hospitalization for new CHF was common in Syrian patients discharged with AF. The clinical predictors of incident CHF emphasize the importance of integrated management of lifestyle risk factors and common comorbidities in AF patients to optimize outcomes in resource-depleted communities.

Sections du résumé

BACKGROUND BACKGROUND
Atrial fibrillation (AF) is the most common arrhythmia worldwide. Data regarding readmission for new congestive heart failure (CHF) following index admission for AF in the developing world are poorly described.
OBJECTIVES OBJECTIVE
The study aimed to assess the rate, predictors, and outcomes of 120-day CHF readmission after index admission for AF in Syria.
METHODS METHODS
This retrospective cohort study collected all adult patients without known CHF who had an index admission with AF to Latakia's tertiary center between June 2021-December 2023. Data were taken from patients' medical notes. The primary outcome included readmission with incident CHF within 120 of index discharge, and secondary outcomes included predictors and outcomes of these CHF readmissions.
RESULTS RESULTS
A total of 660 patients were included in the final analysis, of which 69 (11.7%) were readmitted with new CHF within 120 days of index discharge. Readmitted patients had higher median age (58 vs 70 years,
CONCLUSION CONCLUSIONS
Hospitalization for new CHF was common in Syrian patients discharged with AF. The clinical predictors of incident CHF emphasize the importance of integrated management of lifestyle risk factors and common comorbidities in AF patients to optimize outcomes in resource-depleted communities.

Identifiants

pubmed: 39255054
doi: 10.1177/02676591241283883
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2676591241283883

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Ibrahim Antoun (I)

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Faculty of Medicine, University of Aleppo, Aleppo, Syria.

Alkassem Alkhayer (A)

University of Tishreen's Hospital, Latakia, Syria.

Majed Aljabal (M)

Leicestershire Partnership NHS Trust, Leicester, UK.

Yaman Mahfoud (Y)

University of Tishreen's Hospital, Latakia, Syria.

Alamer Alkhayer (A)

University of Tishreen's Hospital, Latakia, Syria.

Ahmed I Kotb (AI)

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.

Joseph Barker (J)

National Heart and Lung Institute, Imperial College London, London, UK.

Riyaz Somani (R)

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Department of Cardiac Surgery, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.

G André Ng (GA)

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
NIHR Leicester Biomedical Research Centre, Leicester, UK.
Department of Cardiology, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.

Mustafa Zakkar (M)

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Department of Cardiac Surgery, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.
Faculty of Medicine, University of Damascus, Damascus, Syria.

Classifications MeSH